欧美AV

Covalent inhibitors have progressed from serendipitous discoveries to rigorously designed therapeutics with well-defined mechanisms of action. Early concerns about nonspecific reactivity and toxicity once limited their use, but advances in electrophile design, residue selectivity, metabolic stability, and kinetic optimization have demonstrated that covalent mechanisms can be deployed with precision. When appropriately targeted, covalent inhibitors can deliver high cellular potency, enhanced selectivity, and sustained pharmacodynamic effects that are sometimes difficult to achieve with reversible ligands. These features have enabled the successful development of covalent drugs with substantial clinical impact and have broadened the range of proteins considered tractable for small molecule intervention.

This themed issue will highlight contemporary advances in covalent inhibitor medicinal chemistry, and chemical probes that illuminate target biology. By focusing on inhibitors, while welcoming probe-based studies that deepen mechanistic understanding, we aim to showcase how covalent chemistry continues to expand the druggable proteome within a medicinal chemistry framework. Representative topics include:

Manuscripts should be submitted via the journal鈥檚 and the Editorial Office informed by email. Please add a 鈥渘ote to the editor鈥� in the submission form when you submit your manuscript to indicate that this is an open call submission for the themed collection. The Editorial Office reserves the right to check the suitability of submissions in relation to the scope of the collection and inclusion of accepted articles in the collection is not guaranteed.

All manuscripts will be subject to the journal's usual peer review process. Accepted manuscripts will be highlighted together in a dedicated web collection alongside an editorial, regardless of submission date, and there will be no delay in the publication of all accepted manuscripts into regular issues of 欧美AV Medicinal Chemistry.